Investors and Media Relations
Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult to treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs in the inhibition of the Hsp90 chaperone system, the Hedgehog pathway, fatty acid amide hydrolase and phosphoinositol-3-kinase (PI3-kinase) are evidence of its innovative approach to drug discovery and development.
Events
Aug 5, 2010
BMO Capital Markets 10th Annual Focus on Healthcare Conference
Aug 4, 2010
Infinity Pharmaceuticals Second Quarter 2010 Results
more »
Recent Releases
Aug 4, 2010
Infinity Highlights R&D Progress and Announces Second Quarter 2010 Financial Results
Jul 29, 2010
Infinity to Present at BMO Healthcare Conference
more »
|
